Chain Bridge I - Class A

The momentum for this stock is not very good. Chain Bridge I - Class A is not very popular among insiders. Tradey thinks it is not wise to invest in Chain Bridge I - Class A.

News

Short Interest in Chain Bridge I (NASDAQ:CBRG) Increases By 140.0%

Ticker Report Chain Bridge I (NASDAQ:CBRG - Get Free Report) was the target of a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 1,200 shares, a growth of...\n more…

Chain Bridge I (NASDAQ:CBRG) Trading Up 0.3%

Ticker Report Chain Bridge I (NASDAQ:CBRG - Get Free Report) rose 0.3% during trading on Friday . The company traded as high as $11.28 and last traded at $11.28. Approximately 11,857 shares were traded during...\n more…

Chain Bridge I (NASDAQ:CBRG) Shares Up 0.3%

Zolmax Chain Bridge I (NASDAQ:CBRG - Get Free Report) shares rose 0.3% during trading on Friday . The company traded as high as $11.28 and last traded at $11.28. Approximately 11,857 shares were traded...\n more…

Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential

Globe Newswire NEW YORK and SANTA BARBARA, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Phytanix Bio, a pioneering preclinical stage pharmaceutical company dedicated to the development of therapeutics based on...\n more…

$58M Merger: Chain Bridge I Acquires Cannabinoid Medicines Innovator, Eyes Nasdaq Listing

Benzinga Chain Bridge I acquires Phytanix Bio in a $58M deal, advancing cannabinoid medicines and eyeing a Nasdaq listing under ticker PHYX. Read now!\n more…

Chain Bridge I to buy Phytanix Bio

SeekingAlpha.com: All News Phytanix Bio and Chain Bridge I (CBRG) announce business combination creating new public company focused on developing next-generation therapeutics.\n more…